Ceragenix Pharmaceuticals, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by OSMOTICS CORP, was filed 19 May 2008.
Ceragenix Pharmaceuticals, Inc.: what insiders have been doing
Ceragenix Pharmaceuticals, Inc. is a listed company. Its insiders report their share dealings to SEC (Form 4). The past year has been quiet: not a single insider filing for Ceragenix Pharmaceuticals, Inc. The previous disclosure was published on 11 March 2010.
Over the whole record (from 2006), the tally stands at 2 purchases and 7 sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Financial data
· cache
- 60,000 shares@ US$0.25Common stockSEC:0001104659-10-013746:0
- 1,304,569 sharesCommon stockSEC:0001104659-08-034381:0Canonical exit: 13 Aug 2008 (T+90)
- 7,500 sharesCommon stockSEC:0001104659-08-009507:0
- 6,667 shares@ US$1.50Common stockSEC:0001104659-07-066550:0
- 6,667 shares@ US$1.50Common stockSEC:0001104659-07-066551:0
- 10,000 shares@ US$1.25Common stockSEC:0001104659-07-063158:0
- 50,000 shares@ US$1.50Common stockSEC:0001104659-07-051263:0
- 50,000 shares@ US$1.65Common stockSEC:0001104659-07-038890:0
- 10,000 shares@ US$2.10Common StockSEC:0001104659-06-056522:0Canonical exit: 16 Nov 2006 (T+90)
- 150,000 shares@ US$2.00common stockSEC:0001011034-06-000107:0
10 of 10 declarations
About Ceragenix Pharmaceuticals, Inc.
Ceragenix Pharmaceuticals, Inc. is a company focused on developing pharmaceutical products and medical devices. It concentrates on innovative solutions for the treatment of skin diseases and conditions.
